CompoAtlas

ProSolution

ProSolution, licence 80042002: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

Natural health product licensed in Canada

Licence holder
Natural Health Sciences
NPN or DIN-HM
80042002
Status
Active licence
Licence date
29 April 2013
Revision date
9 December 2014
Form
Comprimé
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Terminalia arjuna

Source : Écorce (tige)

1.25 milligrammeNot calculated
Phyllanthus emblica

Source : Fruit

Extraction ratio : 2:1

Dry plant equivalent : 55 mg

Potency : 40.0 Pour cent Tannis

27.5 milligrammeNot calculated
Mucuna pruriens

Source : Graine(s)

100.0 milligrammeNot calculated
Butea superba

Source : Racine

250.0 milligrammeNot calculated
Ophiocordyceps sinensis

Source : Hyphae

Extraction ratio : 4.0:1.0

Dry plant equivalent : 20.0 mg

5.0 milligrammeNot calculated
Eurycoma longifolia

Source : Racine

Extraction ratio : 10.0:1.0

Dry plant equivalent : 1000.0 mg

100.0 milligrammeNot calculated
5,7-Dihydroxy-2-(4-hydroxyphényl)- 4H-1-benzopyran-4-one

Source : Apigénine

100.0 microgrammesNot calculated
5,7-Dihydroxy-2-(4-hydroxyphényl)- 4H-1-benzopyran-4-one

Source : Cynara cardunculus - Feuille

100.0 microgrammesNot calculated
Tribulus terrestris

Source : Feuille

175.0 milligrammeNot calculated
Momordica charantia

Source : Fruit

2.5 milligrammeNot calculated

Non-medicinal ingredients

Cellulose, Dioxyde de titane, Phosphate dicalcique, Hydroxypropylméthylcellulose, Acide stéarique, Croscarmellose de sodium

PopulationAgeQuantity per servingFrequency
Adultes de sexe masculinminimum: 18.0 Année(s)2.0 Comprimé1.0 Jour(s)

Uses authorised in Canada

Zinc and iodine are factors in the maintenance of good health. Zinc helps the body to metabolize carbohydrates, proteins and fats. Zinc helps to maintain immune function. L-arginine is a non-essential amino acid that is involved in protein synthesis. Panax ginseng is used in Herbal Medicine to help support cognitive function and/or reduce mental fatigue. Panax ginseng is used in Herbal Medicine to help enhance physical capacity/performance. Panax ginseng may support physical aspects of sexual health.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80042002

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

List recorded in 2014. Photograph the packaging to check whether it has changed.

Has the product changed? Photograph the packaging.

List recorded in 2014. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line